Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 1913-1921

  Xu, Li ^a   Morari, Elaine Cristina ^b   Wei, Qingyi ^a   Sturgis, Erich M ^a   Ward, Laura S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; ATM GENE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INHERITANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOMA, OXYPHILIC; ADULT; CARCINOMA, PAPILLARY; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

LONCHOCARPUS GLAUCIFOLIUS;

EID: 84861986765     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3299     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D 2011 Global cancer statistics. CA Cancer J Clin 61:69-90
2. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
3. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK 2011 SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute
4. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice Jr JD 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277
5. Prasad KN, Cole WC, Hasse GM 2004 Health risks of low dose ionizing radiation in humans: a review. Exp Biol Med (Maywood) 229:378-382
6. Boice Jr JD, Blettner M, Auvinen A 2000 Epidemiologic studies of pilots and aircrew. Health Phys 79:576-584
7. Jackson SP 2002 Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-696 (Pubitemid 34567505)
8. Derheimer FA, Kastan MB 2010 Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett 584:3675-3681
9. Meyer A, Wilhelm B, Dörk T, Bremer M, Baumann R, Karstens JH, Machtens S 2007 ATM missense variant P1054R predisposes to prostate cancer. Radiother Oncol 83:283-288 (Pubitemid 46915548)
10. Angèle S, Falconer A, Edwards SM, Dörk T, Bremer M, Moullan N, Chapot B, Muir K, Houlston R, Norman AR, Bullock S, Hope Q, Meitz J, Dearnaley D, Dowe A, Southgate C, Ardern-Jones A, Easton DF, Eeles RA, Hall J 2004 ATM polymorphisms as risk factors for prostate cancer development. Br J Cancer 91:783-787 (Pubitemid 39141641)
11. Zheng YL, Kosti O, Loffredo CA, Bowman E, Mechanic L, Perlmutter D, Jones R, Shields PG, Harris CC 2010 Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study. Int J Cancer 126:2199-2210
12. Buchholz TA, Weil MM, Ashorn CL, Strom EA, Sigurdson A, Bondy M, Chakraborty R, Cox JD, McNeese MD, Story MD 2004 A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. Cancer 100:1345-1351 (Pubitemid 38366836)
13. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, Risch A, Wang-Gohrke S, Schürmann P, Bogdanova N, Dörk T, Fagerholm R, Aaltonen K, Blomqvist C, Nevanlinna H, Seal S, Renwick A, StrattonMR, Rahman N, Sangrajrang S, Hughes D, Odefrey F, Brennan P, Spurdle AB, Chenevix-Trench G, Beesley J, Mannermaa A, Hartikainen J, Kataja V, Kosma VM, Couch FJ, Olson JE, Goode EL, Broeks A, Schmidt MK, Hogervorst FB, Van't Veer LJ, Kang D, Yoo KY, Noh DY, Ahn SH, Wedrén S, Hall P, Low YL, Liu J, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Sigurdson AJ, Stredrick DL, Alexander BH, Struewing JP, Pharoah PD, Easton DF 2007 A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352-358 (Pubitemid 46328496)
14. Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ 2006 The ATM missense mutation p.Ser49Cys (c. 146C>G) and the risk of breast cancer. Hum Mutat 27:538-544 (Pubitemid 43865726)
15. Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, Mitsutake N, Kominami R, Yamashita S 2009 Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 16:491-503
16. Wang Y, Cheng J, Li D, Duan H, Yang H, Bin P, Dai Y, Huang C, Liang X, Leng S, Chen W, Zheng Y 2011 Modulation of DNA repair capacity by ataxia telangiectasia mutated gene polymorphisms among polycyclic aromatic hydrocarbons-exposed workers. Toxicol Sci 124:99-108
17. Chen T, Dong B, Lu Z, Tian B, Zhang J, Zhou J, Wu H, Zhang Y, Wu J, Lin P, Zhang J, Xu H, Mo X 2010 A functional single nucleotide polymorphism in promoter of ATM is associated with longevity. Mech Ageing Dev 131:636-640
18. Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J 2003 ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63: 8717-8725 (Pubitemid 38064049)
19. Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS 2005 ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 61:196-202 (Pubitemid 40039123)
20. Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS 2002 ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52:606-613 (Pubitemid 34158720)
21. Pugh TJ, Keyes M, Barclay L, Delaney A, Krzywinski M, Thomas D, Novik K, Yang C, Agranovich A, McKenzie M, Morris WJ, Olive PL, Marra MA, Moore RA 2009 Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachy-therapy patients. Clin Cancer Res 15:5008-5016
22. Sommer SS, Buzin CH, Jung M, Zheng J, Liu Q, Jeong SJ, Moulds J, Nguyen VQ, Feng J, Bennett WP, Dritschilo A 2002 Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls. Cancer Genet Cytogenet 134:25-32 (Pubitemid 34462105)
23. Xu L, Doan PC, Wei Q, Liu Y, Li G, Sturgis EM 2012 Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma. Thyroid 22:35-43
24. Ho T, Li G, Lu J, Zhao C, Wei Q, Sturgis EM 2009 Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 19:129-135
25. Guilhen AC, Bufalo NE, Morari EC, Leite JL, Assumpcao LV, Tincani AJ, Ward LS 2009 Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility. Clin Cancer Res 15:406-412
26. Barbieri RB, Bufalo NE, Secolin R, Silva AC, Assumpção LV, Maciel RM, Cerutti JM, Ward LS 2012 Evidences that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. Eur J Endocrinol 166:241-245
27. Wang HC, Chang WS, Tsai RY, Tsai CW, Liu LC, Su CH, Cheng HN, Tsou YA, Sun SS, Lin CC, Bau DT 2010 Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females. Anticancer Res 30:5217-5221
28. Koren M, Kimmel G, Ben-Asher E, Gal I, Papa MZ, Beckmann JS, Lancet D, Shamir R, Friedman E 2006 ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer 94:1537-1543 (Pubitemid 43772293)
29. Solé X, Guinó E, Valls J, Iniesta R, Moreno V 2006 SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928-1929 (Pubitemid 44283043)
30. Sturgis EM, Li G 2009 Molecular epidemiology of papillary thyroid cancer: in search ofcommongenetic associations. Thyroid 19:1031-1034
31. Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM 1998 ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345 (Pubitemid 28110776)
32. Gutiérrez-Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J 2004 Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Genes Chromosomes Cancer 40:109-119 (Pubitemid 38579879)
33. Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS 2006 Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 108:638-644]
34. Webb EL, Rudd MF, Sellick GS, El Galta R, Bethke L, Wood W, Fletcher O, Penegar S, Withey L, Qureshi M, Johnson N, Tomlinson I, Gray R, Peto J, Houlston RS 2006 Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. Hum Mol Genet 15:3263-3271 (Pubitemid 44605505)
35. Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Burwinkel B, Bartram CR, Meindl A, Schmutzler RK, Cox A, Brock I, Elliott G, Reed MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Schürmann P, Waltes R, Bremer M, Dörk T, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Humphreys K, Liu J, Ahmed S, Dunning AM, Maranian M, Pharoah PD, Chenevix-Trench G, Beesley J, Bogdanova NV, Antonenkova NN, Zalutsky IV, Anton-Culver H, Ziogas A, Brauch H, Ko YD, Hamann U, Fasching PA, Strick R, Ekici AB, Beckmann MW, Giles GG, Severi G, Baglietto L, English DR, Milne RL, Benítez J, Arias JI, Pita G, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo KY, Noh DY, Mannermaa A, Kataja V, Kosma VM, García-Closas M, Chanock S, Lissowska J, Brinton LA, Chang-Claude J, Wang-Gohrke S, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Margolin S, Lindblom A, Humphreys MK, Morrison J, Platte R, Easton DF, Peto J 2010 Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev 19:2143-2151
36. Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Ørntoft T, Lukas J, Bartek J 2005 DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-870 (Pubitemid 40558993)
37. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio Jr RA, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD 2005 Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-913 (Pubitemid 40559004)
38. Kwong LN, Weiss KR, Haigis KM, Dove WF 2008 Atm is a negative regulator of intestinal neoplasia. Oncogene 27:1013-1018 (Pubitemid 351225386)
39. Bau DT, Chang CH, Tsai MH, Chiu CF, Tsou YA, Wang RF, Tsai CW, Tsai RY 2010 Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility. Laryngoscope 120:2417-2422
40. Dong J, Hu Z, Shu Y, Pan S, Chen W, Wang Y, Hu L, Jiang Y, Dai J, Ma H, Jin G, Shen H 7 July 2011 Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis. Mol Carcinog doi: 10.1002/mc.20819
41. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N 2004 Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442 (Pubitemid 38443646)